LEADER 03820namaa2200997uu 4500
001 doab76993
003 oapen
005 20220111
006 m o d
007 cr|mn|---annan
008 220111s2021 xx |||||o ||| 0|eng d
020 |a 9783036524689 
020 |a 9783036524696 
020 |a books978-3-0365-2469-6 
024 7 |a 10.3390/books978-3-0365-2469-6  |2 doi 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
720 1 |a Ulber, Roland  |4 edt 
720 1 |a Ulber, Roland  |4 oth 
245 0 0 |a Bioactive Compounds from Brown Algae 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 online resource (188 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |f Unrestricted online access  |2 star 
520 |a Brown algae comprise approx. 2040 species grown in various climatic conditions. They represent a reservoir of various bioactive compounds, including fucoidan, alginate, phlorotannins, and fucoxanthins. They have shown an array of applications in pharmaceutical and medical fields. Hence, the Guest Editor invites all interested authors to submit their contributions to the current issue in Marine Drugs entitled "Bioactive Compounds from Brown Algae". It aims to highlight different aspects of bioactive compounds found in brown algae, in either research or review articles. Specifically, we are interested in downstream processes, chemistry, biotechnology, and applications of, for example, heteropolysaccharides and other brown algae bioactives. In addition, the structure elucidation and enzymatic modification of these components are also within the scope of the present Issue. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine and Nursing  |2 bicssc 
653 |a 7-phloro-eckol 
653 |a alginate 
653 |a anti-inflammatory 
653 |a anti-lung cancer 
653 |a antifungal 
653 |a antioxidant 
653 |a apoptosis 
653 |a astrocytes 
653 |a bioaccessibility 
653 |a bioactivity 
653 |a biological activities 
653 |a brown algae 
653 |a brown seaweeds 
653 |a cancer 
653 |a coastal area 
653 |a crude lipid extract 
653 |a Dictyosiphon foeniculaceus 
653 |a dieckol 
653 |a fucoidan 
653 |a fucoidanases 
653 |a fucoidans 
653 |a gastrointestinal tract 
653 |a gene expression 
653 |a glioblastoma 
653 |a glycosidic linkages 
653 |a gut microbiota 
653 |a hearing loss 
653 |a hepatic steatosis 
653 |a HepG2/CYP2E1 cells 
653 |a human lung carcinoma A-549 cells 
653 |a laminarin 
653 |a larvicidal 
653 |a lipogenesis 
653 |a molecular masses 
653 |a NMR 
653 |a noise 
653 |a oversulfation 
653 |a oxidative stress 
653 |a PFF-A 
653 |a phlorotannins 
653 |a polyphenol 
653 |a prebiotics 
653 |a retinal pigment epithelium 
653 |a Sargassum aquifolium 
653 |a Sargassum ilicifolium 
653 |a seaweed 
653 |a short-chain fatty acids 
653 |a structure-activity relationships 
653 |a toxicity 
653 |a uveal melanoma 
653 |a VEGF 
793 0 |a DOAB Library. 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/76993  |7 0  |z Open Access: DOAB: description of the publication 
856 4 0 |u https://mdpi.com/books/pdfview/book/4603  |7 0  |z Open Access: DOAB, download the publication